EXACT SCIENCES CORP
DelistedCIK 1124140fmd_0VZT6N5PWMBZWGW10PNVQZ1ECZServices · Services-Medical LaboratoriesTemplate: Standard
Coverage: Jan 01, 2009 to Dec 31, 2025, 64 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 99 | 266 | 454 | 876 | 1,491 | 1,767 | 2,084 | 2,500 | 2,759 | 3,247 |
| Cost of revenue | 45 | 78 | 117 | 217 | 354 | 459 | 661 | 738 | 840 | 984 |
| Net interest income | (0) | (0) | (37) | (62) | – | – | – | – | – | – |
| Gross profit | 54 | 187 | 336 | 660 | 1,137 | 1,308 | 1,423 | 1,762 | 1,919 | 2,263 |
| Research and development | 33 | 42 | 67 | 140 | 554 | 386 | 394 | 427 | 431 | 523 |
| Selling, general and administrative | 190 | 263 | 427 | 738 | 1,071 | 1,663 | 1,593 | 1,628 | 1,676 | 1,939 |
| Total operating expenses | 223 | 305 | 496 | – | – | – | 2,003 | 2,056 | 2,977 | 2,469 |
| Operating income | (169) | (118) | (159) | (234) | (768) | (856) | (594) | (215) | (1,049) | (206) |
| Interest expense | – | 0 | 37 | 199 | 68 | 19 | 20 | 19 | 27 | 39 |
| Interest and investment income | 2 | 4 | 21 | 27 | 7 | 32 | – | – | – | – |
| Other non-operating income (expense) | 2 | 4 | (16) | (173) | (61) | 13 | (39) | 13 | 13 | 2 |
| Income before taxes | (167) | (115) | (175) | (406) | (829) | (843) | (633) | (202) | (1,036) | (204) |
| Income tax expense | – | (0) | 0 | (193) | (5) | (247) | (9) | 2 | (7) | 4 |
| Net income from continuing operations | – | (114) | (175) | (213) | (824) | (596) | (624) | (204) | (1,029) | (208) |
| Net income | (167) | (114) | (175) | (213) | (824) | (596) | (624) | (204) | (1,029) | (208) |
| Net income to common shareholders | (167) | – | – | – | – | – | – | – | – | – |